인사이트
Insights From Our Experts
Articles
Gross-to-Net Improvement Through Holistic Revenue Enhancement
Consistent price increases have long been a staple of commercial strategy for pharmaceutical manufacturers. From this uplift in topline revenue, more sizable discounts can be provided to industry middlemen, like pharmacy benefit managers (PBMs), in order…
Navigating the Cycle of Supply Chain Complexity
As the industry evolves with new regulatory guidelines and product-specific handling requirements, manufacturers now require an agile business model with integrated distribution services. In his new point of view article, Danny Williams, explains how manufacturers can…
Global Biosimilar Competitor Assessment – Who Wins in Biosimilar Access and Why?
The introduction of biosimilar products has created interesting changes in payer behavior across the global markets. For both innovator and biosimilar companies, it has been an effort to understand the demands of payers and succeed in…
How do we pay for a cure?
Setting drug prices is a high-stakes endeavor, and that is especially true for the latest round of gene and curative products coming to market in Europe. Drugmakers need to consider several factors that can help them…
Considerations for Compliance with the EU General Data Protection Regulation (GDPR)
Posted by
Larry Davis, PharmD on 10월 23, 201910/23/19
The General Data Protection Regulation (GDPR) establishes a legal framework that sets guidelines for the collection and processing of personal information from individuals residing in the European Union (EU). GDPR compliance is a challenge for life…
German and United Kingdom Physicians Express Frustration with Health System Challenges
This brief by Health Strategies Insights summarizes preliminary results compiled from twelve 30-minute, one-on-one, in-depth, telephone interviews with a mix of physician specialists from the United Kingdom (U.K.) and Germany. While the physicians discussed benefits of…
Adopting a Patient-Centric Approach to Ensure Safe and Effective Use
Healthcare leaders often talk about ensuring that the right patient receives the right medication at the right time. On its face, this concept seems straightforward. We know that different patients respond differently to different therapies, such…
Facilitating Positive Patient Outcomes At The Frontline
Posted on 10월 10, 201910/10/19
In this new era of outcomes-based healthcare, new therapies are becoming more complex, specialized and data-driven. Demonstrating real-world evidence of a brand’s therapeutic success is dependent on identifying the right patients and sustaining their long-term adherence.…
Innovative Therapies Call for an Integrated Drug Safety and Compliance Model
In this article, Herbert Lee, PharmD, Senior Vice President, Medical Communications and Pharmacovigilance, makes the case for an integrated approach to ensuring the safe and effective use of medications by patients. From emerging therapies to innovative…
Navigating Channel Distribution in a New (and more complex) Biopharma World
Every twist and turn in the bench-to-bedside commercialization journey introduces increasing regulatory complexity, product-specific special handling requirements, and evolving industry guidelines. With more than 300 client case studies to draw from, we’ve found three opportunities (or…